Surgery – Blood drawn and replaced or treated and returned to body – Constituent removed from blood and remainder returned to body
Patent
1994-12-12
1998-07-21
Buiz, Michael Powell
Surgery
Blood drawn and replaced or treated and returned to body
Constituent removed from blood and remainder returned to body
604 4, 424529, 2101952, A61M 3700
Patent
active
057827923
ABSTRACT:
Rheumatoid arthritis is treated by the extra corporeal removal of IgG and IgG-containing circulating immune complexes from the patient's blood. Removal is preferably accomplished by exposing the blood or blood plasma to a protein A immunoadsorbent which binds to IgG-containing immune complexes with high affinity.
REFERENCES:
patent: 4381004 (1983-04-01), Babb
patent: 4464165 (1984-08-01), Pollard, Jr.
patent: 4551435 (1985-11-01), Liberti
patent: 4614513 (1986-09-01), Bensinger
patent: 4627915 (1986-12-01), Kuroda et al.
patent: 4681870 (1987-07-01), Balint
patent: 4685900 (1987-08-01), Honard
patent: 4714556 (1987-12-01), Ambrus et al.
patent: 5356374 (1994-10-01), Hogan et al.
T. Agishi et al., Screening of Immunoadsorbents, Jinko Zoki, vol. 9; p. 264 (1980).
C. Freiburghaus et al., A Summary of Five Years' Clinical Experience with Extensive Removal of Immunoglobulins, Plasma Therapy & Transfusion Technology; vol.7, No.4; pp. 545-550 (Dec. 1986).
P. Geborek et al., Modified Immunosuppression After Apheresis and I.V. Gammaglobulin in Severe Rheumatoid Arthritis, Innov. Tech. Biol. Med.; vol. 6, No. 2; pp. 236-241 (Feb. 13, 1985).
L. D. Johnson et al., Chromatographic Behavior of Histones on Sephadex and Carboxymethylcellulose, Canadian Journal of Biochemistry, vol. 42; pp. 795-811 (1964).
H. M. Lazarus et al., Selective In Vivo Removal of Rheumatoid Factor by an Extracorporeal Treatment Device in Rheumatoid Arthritis Patients, Transfusion, vol. 31, No. 2; pp. 122-128 (1991).
D. Terman et al., Extensive Necrosis of Spontaneous Canine Mammary Adenocarcinoma After Extracorporeal Perfusion Over Staphylococcus Aureus Hostologic, Immunohistochemical, Immunoglogic, and Serologic Findings.sup.1 !, The Journal of Immunology, vol. 124, No. 2; pp. 795-805 (Feb. 1980).
D. Terman, Preliminary Observations of the Effects of Breast Adenocarcinoma of Plasma Perfused Over Immobilized Protein A, The New England Journal of Medicine, vol. 305, No. 20; pp. 1195-1200 (Nov. 12, 1981).
Z. Yamazaki et al., Extracorporeal Immunoadsorption with IM-PH or IM-TR Column, Biomat., Art. Cells., Art. Org., vol. 17, No. 2; pp. 117-124 (1989).
T. Agishi et al., Screening of Immunoadsorbents, Jinko Zoki, vol. 9; p. 264 (1980).
C. Freiburghaus et al., A Summary of Five Years' Clinical Experience with Extensive Removal of Immunoglobulins, Plasma Therapy & Transfusion Technology; vol. 7, No.4; pp. 545-550 (1986).
D. Kiprov et al., Extracorporeal Perfusion of Plasma over Immobilized Protein A in a Patient with Kaposi's Sarcoma and Acquired Immunodeficiency, Journal of Biological Response Modifiers, vol. 3; pp. 341-346 (1984).
F. Roy MacKintosh et al., Treatment of Advanced Malignancy with Plasma Perfused Over Staphylococcal Protein A, The Western Journal of Medicine, vol. 139; pp. 38-40 (1983).
A.K. Schroder et al., Binding of IgM Rheumatoid Factor to Group A, C and G Streptococci with IgG Fc Receptors, Int. Archs Allergy appl. Immun., vol. 80; pp. 52-56 (1986).
Korec et al. (1984) J. Biol. Resp. Mod. 3:330-335.
Terman et al. (1979) The Lancet, Oct. 20 pp. 824-826.
Braude et al., `Specific Microbial Agents of Disease, Aerobic Bacterial or Facultatively Anaerobic Bacteria`, Infectious Diseases and Medical Microbiology, 2nd Ed., pp. 236-237 (1986).
Stites et al., Basic and Clinical Immunology, 7th Ed., pp. 233 and 443-444 (1991).
Schroder et al, "Bindings of IgM Rheumatoid Factor to Group A, C, and G Streptococci with IgG Fc Receptors", Int. Archs Allergy appl. Immun. 80: 52-56 (1986).
MacKintosh et al, "Treatment of Advanced Malignancy with Plasma Perfused Over Staphylococcal Protein A", The Western Journal of Medicine, vol. 139, No. 1, pp. 36-40 (1983).
Kiprov et al, "Extracorporeal Perfusion of Plasma over Immobilized Protein A in Patient with Kaposi's Sarcoma & Acq'd Immunodeficiency", Journal of Biological Response Modifiers, vol. 3, pp. 341-346 (1984).
Balint, Jr. Joseph P.
Jones Frank R.
Snyder, Jr. Harry W.
Buiz Michael Powell
Cypress Bioscience, Inc.
Nguyen A. T.
LandOfFree
Method for treatment of rheumatoid arthritis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of rheumatoid arthritis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of rheumatoid arthritis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1642175